It used to be “The Big Bad Wolf” but now it seems that it’s li’l ol’ me!
The British government is trying to tell us that we cannot talk about the reality of cancer…
From Europe By Karma Singh…
Way back in 2006, the year before I published the first edition of “Cancer? So what?”, I knew someone who worked in a cancer research centre on Long Island NY. At the time, I had a gadget available which I thought might bring about the necessary heavy detoxification and, possibly, save the lives of some late-stage cancer patients. I, therefore, offered, via my acquaintance, to supply four of the gadgets free of charge to test. I did not get an immediate response to my offer.
Around six weeks later, I was informed that they would test the gadgets and it would cost me $50,000.00 per patient! Flabbergasted at such a pecunious response I, of course, asked how on Earth they could come up with such an insane idea.“That’s the amount of money they would lose if a patient recovered instead of dying” was the reply. (sic)
In the intervening years, I have learned that ensuring that people die of cancer is one of the three big sources of income for the medico-pharmaceutical industry.
Every day, around 1,700 people die with cancer in the US alone. Putting all the countries where health care is dominated by the medico-pharmaceutical industry together we come to around 4,500 to 5,000 deaths PER DAY! Times $50,000 equals at least 225 million dollars per DAY, each and every day; times 365.25 gives us just over $82 billions per year in earnings for the medico-pharmaceutical industry.
At the beginning of the 20th century, cancer was so rare that a family doctor could expect to see three cases during his entire professional career.
There is one famous incident in 1911 (another version states that it was in 1903) when a professor at a medical school called all of his students back from vacation because he had just received a cancer patient: The opportunity to study a cancer case was so rare then that he felt perfectly justified in curtailing their vacation.
Following the First World War, for reasons which I make plain in the book, the incidence of cancer began to rapidly rise. It is still rising and is now, after pharmaceutical medicine and heart attacks, the number three cause of death throughout the First World!
You may have heard of Hoxsey and others who found ways of healing cancer. What happened to them, you may wonder? Some sold their discoveries to the medico-pharmaceutical industry in the expectation that they would use them: Others, such as Hoxsey, refused to sell because it became clear that the intent was to bury his discoveries. He and others were hounded to death but continued to help cancer sufferers almost until their last breath.
Recently he had on Dr. Shiva Ayyadurai, the inventor of email, four degrees from MIT (Massachusetts Institute of Technology), founder of several companies, and a candidate for the U.S. Senate from Massachusetts.
Be sure to pre-order Kent Heckenlively’s new book with Dr. Judy Mikovits, PLAGUE OF CORRUPTION from Amazon which you can do RIGHT NOW!

Del has a lengthy interview with Jefferey Jaxen of the Jaxen Report going over the key details regarding all the lawsuits being brought against Opioid drug manufacturers. Dozens of states attorneys general are suing and forcing huge settlements and/or bankruptcies for lying about the safety of these drugs. Purdue Pharma, a family held company, is declaring bankruptcy and the Sackler family who control Purdue are also being sued. You can google for major stories covered by mainstream press for even more details.
People here have much more power than in other states. In 1920, this situation provided ordinary Oklahoma citizens an opportunity to reject an attempt by Big Pharma, through its drug-promoting medical trade group, the American Medical Association, to create a monopoly like they have in all other states.
Think “Bernie Sanders” when you realize the death rate in Marxist countries worldwide, during the 20th century, is estimated to be between 85 million to 100 million.


